Scrub typhus was the most common microbiological diagnosis, and most patients had a doxycycline-treatable cause, underscoring the need to prioritise doxycycline in empirical treatment protocols in ...

The FDA has approved an updated label of Vizamyl to expand the indications for use, allow quantitative analysis of scans, and remove limitations of uses.

XTANDI is the first and only androgen receptor pathway inhibitor (ARPI) indicated and reimbursed in Ontario for use in patients with nmCSPC with biochemical recurrence at high risk for metastasis ...

FDA approves expanded indications for GE HealthCare's Vizamyl PET imaging agent for beta amyloid detection, enabling more precise care for Alzheimer's ...

A Minnesota assassination gives rise to the usual wave of opportunism from both sides of the political spectrum.

More and more patients are operated on during the active phase of infective endocarditis (IE).1 Between 1991 and 1999, in France, the rate of cardiac surgery has increased from 31% to 50%.1 This may, ...

The FDA has approved a tablet version of zanubrutinib for all indications, improving convenience and reducing pill burden for patients with blood cancers.

Johnson & Johnson Innovative Medicine has announced that the European Commission (EC) has approved a Marketing Authorisation (MA) for two new indications of TREMFYA ® (guselkumab), for the treatment ...

The European Medicines Agency is currently reviewing a Type II variation marketing authorization application (MAA) for the new tablet formulation of BRUKINSA in all currently approved indications, ...